Low frequency of N-methyl-D-aspartate receptor autoimmunity in tick-borne encephalitis

Jakob Morén1,2, Barbro Persson3, Anna Sörman3

  • 1Infection Medicine, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

Plos One
|October 13, 2025
PubMed
Abstract

Insights

Autoantibodies against the N-methyl-D-aspartate receptor (anti-NMDAR) rarely develop after tick-borne encephalitis. Further research is needed to understand their role in cognitive issues in some patients.

Area of Science:

  • Neuroimmunology
  • Infectious Diseases
  • Neurology

Background:

  • Tick-borne encephalitis (TBE) is a central nervous system viral infection with poorly understood mechanisms and potential long-term effects.
  • Autoimmune encephalitis, characterized by autoantibodies against the N-methyl-D-aspartate receptor (anti-NMDAR), can be triggered by various events and may complicate recovery from other encephalitides.
  • While TBE has been anecdotally linked to anti-NMDAR encephalitis, the frequency of this autoimmunization is unknown.

Purpose of the Study:

  • To determine the frequency of intrathecal anti-NMDAR antibody development post-TBE.
  • To investigate the potential association between anti-NMDAR antibodies and cognitive complaints in TBE patients.

Main Methods:

  • Retrospective and prospective analysis of adult patients diagnosed with TBE.
  • Detection of anti-NMDAR IgG antibodies in cerebrospinal fluid (CSF) using two commercial kits.
  • Analysis of 71 CSF samples from 53 patients, collected a median of 91 days post-symptom onset.

Main Results:

  • Anti-NMDAR antibodies were detected in CSF samples from one TBE patient.
  • This represents an incidence of 1.9% (95% CI: 0.05-10.1%) of the studied TBE patient cohort.
  • The positive samples were identified using Euroimmun AG kits.

Conclusions:

  • Intrathecal anti-NMDAR autoantibody development following TBE is infrequent.
  • The clinical significance of these antibodies for cognitive outcomes in a subset of patients requires further investigation.
  • Consideration of anti-NMDAR antibody testing in CSF may be warranted for TBE patients experiencing post-recovery clinical decline.

Related Concept Videos

Arboviral Encephalitis01:25

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...